Transfusion-Associated Circulatory Overload (TACO) Draft Revised Reporting Criteria
Transfusion-Associated Circulatory Overload (TACO) Draft Revised Reporting Criteria
Transfusion-Associated Circulatory Overload (TACO) Draft Revised Reporting Criteria
in collaboration with
The International Haemovigilance Network
These proposed surveillance reporting criteria represent a revision of the previous international
TACO definition published by the International Society for Blood Transfusion Haemovigilance working
party and International Haemovigilance Network:
http://www.isbtweb.org/fileadmin/user_upload/Proposed_definitions_2011_surveillance_non_infec
tious_adverse_reactions_haemovigilance_incl_TRALI_correction_2013.pdf
A draft revised version was circulated in December 2014 and tested by contributors from
haemovigilance systems in several countries and continents by applying it to their own cases. This
definition was found to be more inclusive than the 2011 version but limited by the weight placed on
enlargement of the cardiac silhouette and increase of BNP – both are often not investigated or not
recorded in haemovigilance reports.
The revision group recognises that the chief priority is to adopt standard reporting criteria which will
enable professionals to raise awareness of TACO and lead to improved reporting, research and
reduction of transfusion complications. The revision group includes representatives from AABB, and
this opens possibilities for harmonisation. In future, the criteria may need to be adjusted in the light
of accumulating evidence.
Chester Andrzejewski, Paula Bolton-Maggs, Sharran Grey, Kevin Land, Harriet Lucero, Mark
Popovsky, Philippe Renaudier, Pierre Robillard, Matilde Santos, Martin Schipperus, Dafydd Thomas,
Barbee Whitaker, Johanna Wiersum-Osselton (convenor).
Certain clinical conditions, e.g. cardiovascular, renal, pulmonary diseases and severe anemia,
are risk factors for TACO. These conditions do not preclude a diagnosis of TACO.
Other fluids given before or around the time of the transfusion contribute to and can
exacerbate the fluid challenges posed by transfusion. The volume of transfused products
may constitute only a percentage of fluids administered overall.
Patients with TACO cardinally manifest respiratory system-related signs and symptoms such
as tachypnea, dyspnea, and decreased oxygen saturations, typically occurring during or
within 12 hours of transfusion.
Close monitoring of the patient and the vital signs during transfusion are important; review
of vital sign values/net fluid balance for at least 24 hours prior to the transfusion of the unit
identified with the reaction may be of value.
An increase of blood pressure and tachycardia may be warning signs; appropriate clinical
management may prevent development of TACO.
Radiographic chest imaging of adequate quality at the time of the reaction is an important
means of gaining diagnostic information and should be considered. However, cases without
chest imaging may be reported as TACO providing other features are present.
Patients with TACO may experience an increase in body temperature. An increase of body
temperature should be investigated according to protocol and clinical judgement. Increased
body temperature does not exclude TACO if the reporting criteria are met.
Patients receiving ventilatory support: In ICU patients who may be receiving varying degrees
of PEEP (positive end expiratory pressure) ventilatory support, pulmonary oedema may be
difficult to diagnose at higher PEEP settings with TACO becoming apparent only if PEEP
settings are reduced or ventilation is discontinued.
Patients classified with a TACO (surveillance diagnosis) should have acute or worsening respiratory
compromise during or up to 12 hours after transfusion and should exhibit two or more of the criteria
below:
Evidence of acute or worsening pulmonary oedema based on:
o clinical physical examination (see Note 1), and/or
o radiographic chest imaging and/or other non-invasive assessment of cardiac function e.g.
echocardiogram (see Note 2)
Notes
1. Clinical findings could include crackles on lung auscultation, orthopnea and cough, cyanosis
and decreased oxygen saturation values in the absence of other specific causes.
Imputability
The imputability, the causal contribution of the transfusion, is assessed separately.